Skip to main content
Signal8

Trevena, Inc. (TRVN)

Trevena, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing innovative pharmaceutical solutions for individuals suffering from central nervous system disorders. Its pipeline features several promising drug candidates: OLINVYK (Oliceridine) injection: A G protein-biased mu-opioid receptor (MOR) ligand engineered to manage acute pain ranging from moderate to severe. TRV027: Aimed at addressing acute lung injury, which contributes to acute respiratory distress syndrome (ARDS) and abnormal blood clotting in patients with COVID-19. TRV250: A G protein-biased delta-opioid receptor agonist under development for the treatment of acute migraine. TRV734: A small molecule G protein-biased MOR ligand designed for the management of both moderate-to-severe acute and chronic pain. TRV045: An innovative S1P modulator focused on providing relief for chronic pain. The company has also established a partnership with Imperial College London to investigate TRV027's potential in patients afflicted with COVID-19. Trevena, Inc., founded in 2007, operates from its headquarters in Chesterbrook, Pennsylvania.

Sector: Biotechnology

Industry: Biotechnology

Trevena, Inc. logo

Trevena, Inc.

OTC:TRVNHealthcare
$0.0005
CLOSED
Mkt Cap$432
EV-
Float810K
O/S864K
VOL977 sh
$ Vol$0
RVOL2.18×
Inst Own0.0%
SI0.4%
Net Cash/Sh-
Dilution
Trevena, Inc. logoOTC:TRVNClosed$0.0005
Financials Summary
Revenue$3.13M
Net Income-$40.29M
Total Assets$40.6M
Free Cash Flow-$33.08M
Debt & Equity
Debt 127%
Total Debt$36.24M
Total Equity-$7.66M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
  1. 1:25Reverse split
    Aug 13, 202425 shares → 1
  2. 1:25Reverse split
    Nov 10, 202225 shares → 1
Balance Sheet Details
Assets$40.6M
Liabilities$48.26M
Accounts Receivable$0
Accounts Payable$2.3M
Inventory$0
PP&E (Net)$4.86M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue$3.13M-$418K$567K$3.07M$31K$5.73M$0$3.75M$6.25M$0$135K$808K$2.42M
YoY Growth-847.6%-173.7%-81.5%9800.0%-99.5%---40.0%---83.3%-66.6%-
Cost of Revenue$1.67M$3.02M$954K$182K$108K$0$490K$0$44.07M$40.55M$18.76M$13.29M$0
Gross Profit$1.46M-$3.44M-$387K$2.89M-$77K$5.73M-$490K$3.75M-$37.82M-$40.55M-$18.63M-$12.49M$2.42M
Gross Margin46.6%822.0%-68.3%94.1%-248.4%100.0%-100.0%-605.2%--13800.0%-1546.2%100.0%
Research and Development$16.33M$18.21M$13.43M$13.12M$13.29M$15.82M$48.97M$89.96M$44.07M$40.55M$18.76M$13.29M$15.11M
Selling, General, and Administrative$20.41M$34.73M$38.11M$19.25M$13.21M$18.98M$19.64M$16.08M$12.8M$9.4M$4.72M$3.12M$3.06M
Other$0$0$0$0$0$0$614K-$711K$93K$184K$1K$123K$0
Total Operating Expenses$36.74M$52.94M$51.54M$32.37M$26.5M$34.8M$68.61M$106.03M$56.87M$49.95M$23.48M$16.42M$18.17M
Operating Income (EBIT)-$35.29M-$56.38M-$51.92M-$29.48M-$26.58M-$30.5M-$70.39M-$102.28M-$50.62M-$49.95M-$23.35M-$15.61M-$15.75M
Operating Margin-1129.2%13486.8%-9157.8%-960.7%-85741.9%-532.1%--2727.5%-809.9%--17295.4%-1932.9%-650.5%
Interest Expense$0$1.26M$1K$29K$931K$2.23M$2.78M$1.74M$334K$71K$150K$194K$74K
Interest Income$2.25M$451K$162K$240K$418K$1M$679K$743K$331K$17K$884$754$4K
Other Income (Expense)-$4.68M$2.71M$337K$416K$1.71M$459K-$3.25M-$711K$93K$249K$94K-$26K-$60K
Income Before Tax (EBT)-$39.97M-$53.67M-$51.59M-$29.07M-$24.87M-$30.04M-$71.86M-$102.99M-$50.53M-$49.7M-$23.25M-$15.64M-$15.81M
Income Tax Expense$318K$0$0$300K$0$745K$3.39M-$246K-$208K$255K$151K$0$74K
Net Income-$40.29M-$53.67M-$51.59M-$29.37M-$24.87M-$30.78M-$71.86M-$102.99M-$50.53M-$49.7M-$23.25M-$15.64M-$15.81M
Net Income Margin-1289.2%12839.1%-9098.4%-957.0%-80229.0%-537.1%--2746.5%-808.5%--17225.8%-1936.1%-652.9%
Supplementary Data
EPS-3.16-7.59-7.90-5.75-7.65-10.46-30.23-49.14-28.84-50.40-22.59-28.41-38.03
Diluted EPS-3.16-7.59-7.90-5.75-7.65-10.46-30.23-49.14-28.84-50.40-22.59-28.41-38.03
Weighted Average OS14.19M7.07M6.53M5.10M3.67M2.94M2.38M2.10M1.75M986,2241.03M550,432415,723
EBITDA-$34.95M-$52.03M-$51.08M-$28.66M-$23.38M-$28.43M-$68.12M-$101.01M-$50.62M-$49.71M-$22.64M-$14.65M-$14.95M
EBITDA Margin-1118.5%12447.8%-9009.5%-933.7%-75412.9%-495.9%--2693.6%-809.9%--16771.8%-1814.6%-617.2%
Balance Sheet
PeriodFY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Assets
Current Assets
Cash and Cash Equivalents$32.98M$38.32M$66.92M$109.4M$32.3M$32.89M$16.56M$24.27M$46.77M$36.21M$37.97M$6.74M$17.06M
Short-Term Investments$0$0$0$0$3.5M$28.59M$49.54M$86.33M$125.86M$70.7M$0$0$0
Cash and Short-Term Investments$32.98M$38.32M$66.92M$109.4M$35.8M$61.48M$66.1M$110.6M$172.64M$106.9M$37.97M$6.74M$17.06M
Accounts Receivable$0$0$0$71K$0$0$0$0$0$0$0$12K$23K
Inventory$0$906K$2.35M$0$0$0$0$0$0$0$0$102K$92K
Other Current Assets$2.23M$1.78M$1.45M$9M$0$0$0$0$1.89M$669K$2M$102K$92K
Total Current Assets$35.2M$41.01M$70.72M$119.04M$37.49M$62.09M$67.49M$112.39M$174.53M$107.57M$41.92M$7.01M$17.44M
Long-Term Assets
Property, Plant & Equipment Net$4.86M$5.71M$6.55M$7.37M$8.18M$3.39M$3.81M$1.06M$696K$553K$343K$910K$1.68M
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$11K$13K$15K$0$0$0$0
Long-Term Investments$540K$1.96M$1.31M$1.31M$1.31M$1.3M$1.41M$1.19M$113K$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0-$1.41M-$1.19M-$113K$0$0$0$0
Other Long-Term Assets$0$0$1.54M$13K$20K$0$1.41M$1.19M$113K$211K$128K$170K$296K
Total Long-Term Assets$5.4M$7.67M$9.4M$8.7M$9.51M$4.69M$5.23M$2.27M$824K$764K$471K$1.08M$1.97M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$40.6M$48.68M$80.12M$127.74M$46.99M$66.78M$72.72M$114.65M$175.35M$108.34M$42.39M$8.09M$19.41M
Liabilities
Current Liabilities
Accounts Payable$2.3M$2.37M$4.55M$1.69M$1.05M$1.42M$1.42M$8.75M$6.75M$4.34M$545K$459K$623K
Short-Term Debt$0$0$0$0$5.04M$12.56M$12.43M$5.04M$0$0$0$2.09M$194K
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$5.17M$0$0$0$0$3.75M$0$0$0$0
Other Current Liabilities$2.09M$1.97M$2.13M$6.08M$1.79M$1.73M$2.55M$2.73M$2.64M$1.67M$893K$852K$784K
Total Current Liabilities$7.55M$8.73M$9.19M$16.56M$9.11M$17.49M$18.21M$22.05M$13.57M$6.96M$2.74M$3.93M$2.28M
Long-Term Liabilities
Long-Term Debt$30.81M$13.43M$0$0$0$4.81M$15.72M$13.27M$18.19M$1.69M$0$2.78M$251K
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$5.47M$5.48M-$1$6K$5K$2.93M$4.12M$737K$455K$471K$664K$1.41M$1.34M
Total Long-Term Liabilities$40.71M$24.35M$6.31M$7.11M$7.81M$7.76M$19.88M$14.03M$18.65M$2.17M$664K$4.2M$1.71M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$48.26M$33.08M$15.49M$23.67M$16.92M$25.25M$38.09M$36.07M$32.22M$9.13M$3.4M$8.13M$3.99M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$108.34B$120.56M$58.96M$58.64M
Common Stock$17K$8K$165K$160K$94K$82K$62K$56K$51K$39K$958$682$654
Retained Earnings-$588.06M-$547.77M-$494.1M-$442.51M-$413.14M-$388.27M-$357.49M-$285.63M-$182.5M-$131.97M-$82.27M-$59.02M-$43.38M
Comprehensive Income & Other$0$1K$0$0$0-$9K-$42K$2K-$206K-$19K-$3.93M-$3.23M-$2.44M
Other Stockholders' Equity$580.39M$563.36M$558.57M$546.42M$443.13M$429.72M$392.06M$364.15M$325.58M$231.13M$121.26M$58.98M$58.8M
Total Equity-$7.66M$15.6M$64.63M$104.07M$30.08M$41.53M$34.63M$78.58M$143.13M$99.2M$38.99M-$39K$15.42M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$40.6M$48.68M$80.12M$127.74M$46.99M$66.78M$72.72M$114.65M$175.35M$108.34M$42.39M$8.09M$19.41M
Supplementary Data
Total Debt$36.24M$19.77M$7.1M$7.8M$13.46M$17.39M$28.18M$18.33M$18.19M$1.8M$0$4.87M$445K
Net Debt$3.27M-$18.55M-$59.82M-$101.6M-$18.84M-$15.5M$11.62M-$5.94M-$28.58M-$34.4M-$37.97M-$1.87M-$16.62M
Cash Flow Statement
PeriodFY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Operating Activities
Net Income-$40.29M-$53.67M-$51.59M-$29.37M-$24.87M-$30.78M-$71.86M-$102.99M-$50.53M-$49.7M-$23.25M-$15.64M-$15.81M
Depreciation & Amortization$334K$382K$428K$477K$562K$645K$490K$246K$208K$239K$707K$788K$802K
Deferred Income Tax$0$0-$6K$3K-$360K-$14K$479K$1.27M$1.29M-$117K-$241K-$45K-$6K
Stock-Based Compensation$2.93M$3.68M$4.41M$3.28M$3.23M$4.37M$6.39M$5.9M$3.43M$2.38M$928K$176K$181K
Changes in Working Capital:
  Accounts Receivable$522K$1.21M-$2.34M$1.05M-$1.12M$0$0$0$0$0$0$0$0
  Inventory$10K-$624K-$2.35M-$3.41M$1.12M$0$0$0$0$0$0$0$0
  Accounts Payable-$1.4M-$676K$1.53M$3.41M-$1.26M-$1.16M-$8.41M$7.13M$2.82M$4.19B$1.17B$0$0
  Other Working Capital$512K-$758K-$695K$2.8M-$1.6M-$375K$612K-$3.65M$2.53M-$4.18B-$1.17B-$138K$1.54M
Total Working Capital Change-$355K-$849K-$3.85M$3.85M-$2.86M-$375K-$7.8M$3.48M$5.35M$7.38M-$2.5M-$138K$1.54M
Other Non-Cash Items$4.34M-$1.02M$413K$361K$632K$786K$1.05M$534K$180K$33K$121K$49K$11K
Net Cash from Operating-$33.03M-$51.48M-$50.2M-$21.39M-$23.67M-$25.38M-$71.25M-$91.55M-$40.07M-$39.78M-$24.24M-$14.81M-$13.28M
Investing Activities
Capital Expenditures-$41K-$28K-$16K-$27K$0-$169K-$3.5M-$605K-$376K-$440K-$140K-$21K-$98K
Acquisitions$0-$46K$0$0$0-$21M$0$0$0$0$0$0$0
Purchases of Investments$0-$32.95M$0$0-$53.81M-$47.81M-$62.74M-$77.42M-$56.56M-$70.72M$0$0$0
Sales of Investments$0$33M$0$3.5M$79.39M$68.98M$99.02M$115.82M$0$0$0$0$0
Other Investing Activities$0$46K$0$0$0$21M$36.27M$38.4M-$56.58M-$70.72M$0$0$0
Net Cash from Investing-$41K$18K-$16K$3.47M$25.58M$21M$32.78M$37.8M-$56.94M-$71.16M-$140K-$21K-$98K
Financing Activities
Debt Repaid-$14.76M-$13.9M$8K$5.05M$12.68M$12.68M-$9.91M$4K-$16.36M-$1.77M$4.95M-$4.5M$903K
Common Stock Issuance$11.55M$8M$7.95M$101.01M$10.31M$33.2M$20.71M$32.08M$90.31M$107.29M$59.92B$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$2K-$37K-$206K-$935K-$130K$83K$361K$256K$906K$112K$634K$3K$0
Net Cash from Financing$26.31M$23.5M$7.73M$95.02M-$2.5M$20.6M$30.99M$32.33M$107.58M$109.18M$55.61M$4.51M$16.58M
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$6.76M-$27.95M-$42.48M$77.1M-$581K$16.23M-$7.49M-$21.43M$10.57M-$1.76M$31.23M-$10.32M$3.2M
Supplementary Data
Operating Cash Flow-$33.03M-$51.48M-$50.2M-$21.39M-$23.67M-$25.38M-$71.25M-$91.55M-$40.07M-$39.78M-$24.24M-$14.81M-$13.28M
Capital Expenditure-$41K-$28K-$16K-$27K$0-$169K-$3.5M-$605K-$376K-$440K-$140K-$21K-$98K
Free Cash Flow-$33.08M-$51.51M-$50.21M-$21.42M-$23.67M-$25.54M-$74.75M-$92.16M-$40.45M-$40.22M-$24.38M-$14.83M-$13.38M
Cash at Beginning$40.28M$68.23M$110.71M$33.61M$34.2M$17.97M$25.46M$46.89M$36.21M$37.97M$6.74M$17.06M$13.86M
Cash at End$33.52M$40.28M$68.23M$110.71M$33.61M$34.2M$17.97M$25.46M$46.77M$36.21M$37.97M$6.74M$17.06M